| PI3K inhibitors prime neuroblastoma cells for chemotherapy by shifting the balance towards pro-apoptotic Bcl-2 proteins and enhanced mitochondrial apoptosis. | |
| | |
MedLine Citation:
|
PMID: 20856197 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
We recently identified activation of phosphatidylinositol 3'-kinase (PI3K)/Akt as a novel predictor of poor outcome in neuroblastoma. Here, we investigated the effect of small-molecule PI3K inhibitors on chemosensitivity. We provide first evidence that PI3K inhibitors, for example PI103, synergize with various chemotherapeutics (Doxorubicin, Etoposide, Topotecan, Cisplatin, Vincristine and Taxol) to trigger apoptosis in neuroblastoma cells (combination index: high synergy). Mechanistic studies reveal that PI103 cooperates with Doxorubicin to reduce Mcl-1 expression and Bim(EL) phosphorylation and to upregulate Noxa and Bim(EL) levels. This shifted ratio of pro- and antiapoptotic Bcl-2 proteins results in increased Bax/Bak conformational change, loss of mitochondrial membrane potential, cytochrome c release, caspase activation and caspase-dependent apoptosis. Although Mcl-1 knockdown enhances Doxorubicin- and PI103-induced apoptosis, silencing of Noxa, Bax/Bak or p53 reduces apoptosis, underscoring the functional relevance of the Doxorubicin- and PI103-mediated modulation of these proteins for chemosensitization. Bcl-2 overexpression inhibits Bax activation, mitochondrial perturbations, cleavage of caspases and Bid, and apoptosis, confirming the central role of the mitochondrial pathway for chemosensitization. Interestingly, the broad-range caspase inhibitor zVAD.fmk does not interfere with Bax activation or mitochondrial outer membrane permeabilization, whereas it blocks caspase activation and apoptosis, thus placing mitochondrial events upstream of caspase activation. Importantly, PI103 and Doxorubicin cooperate to induce apoptosis and to suppress tumor growth in patients' derived primary neuroblastoma cells and in an in vivo neuroblastoma model, underlining the clinical relevance of the results. Thus, targeting PI3K presents a novel and promising strategy to sensitize neuroblastoma cells for chemotherapy-induced apoptosis, which has important implications for the development of targeted therapies for neuroblastoma. |
| | |
Authors:
|
A Bender; D Opel; I Naumann; R Kappler; L Friedman; D von Schweinitz; K-M Debatin; S Fulda |
Related Documents
:
|
20419447 - Systematic genetic dissection of p14arf-mediated mitochondrial cell death signaling rev... 15541727 - Survivin interacts with smac/diablo in ovarian carcinoma cells but is redundant in smac... 10951587 - Requirement for caspase activation in monocytic differentiation of myeloid leukemia cells. 16533807 - Apoptosis induction by activator protein 2alpha involves transcriptional repression of ... 8207807 - Priming of immature thymocytes to cd3-mediated apoptosis by infection with murine cytom... 12018387 - 7,8-dihydroneopterin induces apoptosis of jurkat t-lymphocytes via a bcl-2-sensitive pa... |
Publication Detail:
|
Type: Journal Article Date: 2010-09-20 |
Journal Detail:
|
Title: Oncogene Volume: 30 ISSN: 1476-5594 ISO Abbreviation: Oncogene Publication Date: 2011 Jan |
Date Detail:
|
Created Date: 2011-01-28 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8711562 Medline TA: Oncogene Country: England |
Other Details:
|
Languages: eng Pagination: 494-503 Citation Subset: IM |
Affiliation:
|
Department of Hematology/Oncology, University Children's Hospital, Ulm, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Human AP endonuclease (APE1/Ref-1) and its acetylation regulate YB-1-p300 recruitment and RNA polyme...
Next Document: Caspase-3 cleaves XIAP in a positive feedback loop to sensitize melanoma cells to TRAIL-induced apop...